HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aconitine linoleate, a natural lipo-diterpenoid alkaloid, stimulates anti-proliferative activity reversing doxorubicin resistance in MCF-7/ADR breast cancer cells as a selective topoisomerase IIα inhibitor.

Abstract
Aconitine linoleate (1) is a lipo-diterpenoid alkaloid, isolated from Aconitum sinchiangense W. T. Wang. The study aimed at investigating the anti-proliferative efficacy and the underlying mechanisms of 1 against MCF-7 and MCF-7/ADR cells, as well as obvious the safety evaluation in vivo. The cytotoxic activities of 1 were measured in vitro. Also, we investigated the latent mechanism of 1 by cell cycle analysis in MCF-7/ADR cells and topo I and topo IIα inhibition assay. Molecular docking is done by Discovery Studio 3.5 and Autodock vina 1.1.2. Finally, the acute toxicity of 1 was detected on mice. 1 exhibited significant antitumor activity against both MCF-7 and MCF-7/ADR cells, with IC50 values of 7.58 and 7.02 μM, which is 2.38 times and 5.05 times more active, respectively than etoposide in both cell lines, and being 9.63 times more active than Adriamycin in MCF-7/ADR cell lines. The molecular docking and the topo inhibition test found that it is a selective inhibitor of topoisomerase IIα. Moreover, activation of the damage response pathway of the DNA leads to cell cycle arrest at the G0G1 phase. Furthermore, the in vivo acute toxicity of 1 in mice displayed lower toxicity than aconitine, with LD50 of 2.2 × 105 nmol/kg and only slight pathological changes in liver and lung tissue, 489 times safer than aconitine. In conclusion, compared with aconitine, 1 has more significant anti-proliferative activity against MCF-7 and MCF-7/ADR cells and greatly reduces in vivo toxicity, which suggests this kind of lipo-alkaloids is powerful and promising antitumor compounds for breast cancer.
AuthorsShangxian Luan, Yingying Gao, Xiaoxia Liang, Li Zhang, Qiang Wu, Yunkai Hu, Lizi Yin, Changliang He, Shixi Liu
JournalNaunyn-Schmiedeberg's archives of pharmacology (Naunyn Schmiedebergs Arch Pharmacol) Vol. 395 Issue 1 Pg. 65-76 (01 2022) ISSN: 1432-1912 [Electronic] Germany
PMID34727218 (Publication Type: Comparative Study, Journal Article)
Copyright© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Chemical References
  • Antibiotics, Antineoplastic
  • Poly-ADP-Ribose Binding Proteins
  • Doxorubicin
  • Linoleic Acid
  • DNA Topoisomerases, Type II
  • TOP2A protein, human
  • Aconitine
Topics
  • Aconitine (administration & dosage, pharmacology, toxicity)
  • Aconitum (chemistry)
  • Animals
  • Animals, Outbred Strains
  • Antibiotics, Antineoplastic (pharmacology)
  • Breast Neoplasms (drug therapy)
  • Cell Proliferation (drug effects)
  • DNA Topoisomerases, Type II
  • Doxorubicin (pharmacology)
  • Drug Resistance, Neoplasm (drug effects)
  • Female
  • Humans
  • Inhibitory Concentration 50
  • Linoleic Acid (chemistry)
  • MCF-7 Cells
  • Male
  • Mice
  • Molecular Docking Simulation
  • NIH 3T3 Cells
  • Poly-ADP-Ribose Binding Proteins (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: